Additionally, the 36-month beta value for SGHT is 2.74. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SGHT is 26.52M and currently, short sellers hold a 4.74% ratio of that float. The average trading volume of SGHT on April 26, 2024 was 173.41K shares.
SGHT) stock’s latest price update
Sight Sciences Inc (NASDAQ: SGHT)’s stock price has gone decline by -8.54 in comparison to its previous close of 5.62, however, the company has experienced a -1.91% decrease in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-18 that MENLO PARK, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
SGHT’s Market Performance
Sight Sciences Inc (SGHT) has experienced a -1.91% fall in stock performance for the past week, with a 2.19% rise in the past month, and a 7.64% rise in the past quarter. The volatility ratio for the week is 9.71%, and the volatility levels for the past 30 days are at 8.61% for SGHT. The simple moving average for the past 20 days is -6.56% for SGHT’s stock, with a 7.89% simple moving average for the past 200 days.
Analysts’ Opinion of SGHT
Piper Sandler, on the other hand, stated in their research note that they expect to see SGHT reach a price target of $5.50, previously predicting the price at $15. The rating they have provided for SGHT stocks is “Neutral” according to the report published on September 12th, 2023.
BofA Securities gave a rating of “Underperform” to SGHT, setting the target price at $4.50 in the report published on September 12th of the previous year.
SGHT Trading at 4.78% from the 50-Day Moving Average
After a stumble in the market that brought SGHT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.11% of loss for the given period.
Volatility was left at 8.61%, however, over the last 30 days, the volatility rate increased by 9.71%, as shares sank -0.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +23.56% upper at present.
During the last 5 trading sessions, SGHT fell by -1.91%, which changed the moving average for the period of 200-days by -31.65% in comparison to the 20-day moving average, which settled at $5.50. In addition, Sight Sciences Inc saw -0.39% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGHT starting from Badawi Paul, who sale 12,571 shares at the price of $5.08 back on Apr 03 ’24. After this action, Badawi Paul now owns 5,750,729 shares of Sight Sciences Inc, valued at $63,848 using the latest closing price.
Bauerlein Alison, the Chief Financial Officer of Sight Sciences Inc, sale 10,123 shares at $5.08 during a trade that took place back on Apr 03 ’24, which means that Bauerlein Alison is holding 426,248 shares at $51,415 based on the most recent closing price.
Stock Fundamentals for SGHT
Current profitability levels for the company are sitting at:
- -0.71 for the present operating margin
- 0.85 for the gross margin
The net margin for Sight Sciences Inc stands at -0.69. The total capital return value is set at -0.37. Equity return is now at value -39.64, with -29.26 for asset returns.
Based on Sight Sciences Inc (SGHT), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -1.37. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -10.59.
Currently, EBITDA for the company is -56.66 million with net debt to EBITDA at 1.99. When we switch over and look at the enterprise to sales, we see a ratio of 1.88. The receivables turnover for the company is 5.67for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.29.
Conclusion
In conclusion, Sight Sciences Inc (SGHT) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
